Total Payments
$43,225
2024 Payments
$11,081
Companies
26
Transactions
129
Medicare Patients
473
Medicare Billing
$61,040
Payment Breakdown by Category
Other$29,195 (67.5%)
Food & Beverage$8,373 (19.4%)
Travel$5,558 (12.9%)
Education$99.02 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,195 | 11 | 67.5% |
| Food and Beverage | $8,373 | 104 | 19.4% |
| Travel and Lodging | $5,558 | 13 | 12.9% |
| Education | $99.02 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $12,869 | 36 | $0 (2024) |
| Gilead Sciences, Inc. | $9,961 | 26 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $9,424 | 17 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $7,504 | 12 | $0 (2017) |
| Madrigal Pharmaceuticals | $745.44 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $399.71 | 5 | $0 (2024) |
| PFIZER INC. | $353.25 | 3 | $0 (2023) |
| Shionogi Inc | $242.19 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $242.18 | 2 | $0 (2021) |
| Aries Pharmaceuticals, Inc. | $210.13 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,081 | 33 | Phathom Pharmaceuticals, Inc. ($9,424) |
| 2023 | $1,050 | 10 | Gilead Sciences, Inc. ($466.72) |
| 2022 | $346.41 | 4 | ABBVIE INC. ($139.78) |
| 2021 | $310.35 | 4 | AstraZeneca Pharmaceuticals LP ($117.18) |
| 2020 | $329.00 | 3 | PFIZER INC. ($124.91) |
| 2019 | $773.20 | 10 | Shionogi Inc ($242.19) |
| 2018 | $764.69 | 9 | AbbVie, Inc. ($380.01) |
| 2017 | $28,570 | 56 | AbbVie, Inc. ($11,774) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $115.15 | General |
| Category: LIVER DISEASE | ||||||
| 12/07/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $134.20 | General |
| Category: GI | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $133.20 | General |
| Category: VIROLOGY | ||||||
| 11/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $136.90 | General |
| Category: LIVER DISEASE | ||||||
| 11/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $147.24 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $58.59 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $141.67 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $135.47 | General |
| Category: LIVER DISEASE | ||||||
| 10/27/2024 | Phathom Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.48 | General |
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $115.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $149.59 | General |
| Category: INFLAM | ||||||
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $55.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $35.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $792.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $346.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $41.36 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 234 | 286 | $322,766 | $30,745 |
| 2022 | 4 | 84 | 98 | $70,440 | $9,095 |
| 2021 | 2 | 31 | 36 | $18,594 | $3,692 |
| 2020 | 4 | 124 | 176 | $50,472 | $17,508 |
Total Patients
473
Total Services
596
Medicare Billing
$61,040
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 74 | $55,870 | $7,461 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 62 | $51,603 | $6,823 | 13.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $42,290 | $5,040 | 11.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $34,048 | $4,040 | 11.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 42 | $20,889 | $2,773 | 13.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $35,030 | $2,142 | 6.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 16 | $41,991 | $1,308 | 3.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $41,045 | $1,159 | 2.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 39 | 43 | $36,808 | $4,846 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $13,488 | $1,739 | 12.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 22 | $9,961 | $1,297 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 17 | $10,183 | $1,213 | 11.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 21 | $12,957 | $2,444 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $5,637 | $1,248 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 46 | 73 | $19,866 | $6,630 | 33.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 38 | 39 | $17,458 | $5,725 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 42 | $7,098 | $2,721 | 38.3% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 22 | 22 | $6,050 | $2,432 | 40.2% |
About Dr. George Abdelsayed, MD
Dr. George Abdelsayed, MD is a Gastroenterology healthcare provider based in New Brunswick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144298613.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Abdelsayed, MD has received a total of $43,225 in payments from pharmaceutical and medical device companies, with $11,081 received in 2024. These payments were reported across 129 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,195).
As a Medicare-enrolled provider, Abdelsayed has provided services to 473 Medicare beneficiaries, totaling 596 services with total Medicare billing of $61,040. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine, Gastroenterology
- Location New Brunswick, NJ
- Active Since 03/10/2006
- Last Updated 07/23/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144298613
Products in Payments
- VOQUEZNA (Drug) $9,405
- ZEPATIER (Drug) $7,493
- Mavyret (Drug) $7,319
- Vosevi (Drug) $5,571
- Viekira (Drug) $4,446
- Epclusa (Drug) $1,331
- REZDIFFRA (Drug) $450.88
- XIFAXAN (Drug) $316.38
- RESMETIROM (Drug) $294.56
- MAVYRET (Drug) $253.50
- XELJANZ (Drug) $249.91
- Mulpleta (Drug) $242.19
- Vemlidy (Drug) $238.80
- RINVOQ (Biological) $156.69
- Livdelzi (Drug) $149.59
- Linzess (Drug) $134.20
- Cook Medical (Device) $125.25
- BYDUREON (Drug) $125.00
- VRAYLAR (Drug) $124.98
- DALVANCE (Drug) $122.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New Brunswick
Dr. Vinod Rustgi, Md, MD
Gastroenterology — Payments: $555,573
Gastroenterology $555,573
Lea Chen, M.d, M.D
Gastroenterology — Payments: $179,886
Gastroenterology $179,886
Arvind Trindade, Md, MD
Gastroenterology — Payments: $91,569
Gastroenterology $91,569
Dr. Avik Sarkar, M.d, M.D
Gastroenterology — Payments: $12,779
Gastroenterology $12,779
Dr. Vishal Jain, Md, MD
Gastroenterology — Payments: $9,858
Gastroenterology $9,858
Dr. Prateek Chapalamadugu, M.d, M.D
Gastroenterology — Payments: $7,913
Gastroenterology $7,913